Q&A: Steroids, not anti-TNF therapy increase risk for severe COVID-19 infection in IBD

For patients with inflammatory bowel disease, risk factors associated with severe COVID-19 infection included increasing age, comorbidities and corticosteroid use, according to an initial analysis of a large, international registry.The Surveillance Epidemiology of Coronavirus Under Research Exclusion-IBD (SECURE-IBD) registry was recently launched to monitor and report outcomes of COVID-19 in patients with IBD. The registry aimed to answer questions that patients with IBD and their caregivers may have. The Icahn School of Medicine at Mount Sinai collaborated with the University of NorthRead More

Share on facebook
Share on twitter
Share on linkedin